logo
Calvary maternity services hiring midwives as solution to Hobart Private Hospital Healthscope exit from maternity

Calvary maternity services hiring midwives as solution to Hobart Private Hospital Healthscope exit from maternity

A plan to save private maternity services in southern Tasmania is underway after their future was thrown into doubt in February.
On June 10, a consortium of health organisations began the 11-week transition, which will increase Calvary Lenah Valley Hospital's annual birthing capacity from 350 beds to 900.
The increase is aimed at allowing the hospital to gradually absorb a shortfall in maternity beds left by Hobart Private Hospital, which will close its maternity services on August 20.
Hobart Private would usually manage about 500 births per year, while Calvary handles about 380 to 390.
At a public forum on Tuesday, Calvary Health Care reported that hiring and expansion plans were currently meeting or exceeding expectations.
Staffing the expanded offering has been top of mind as a make-or-break issue because Tasmania has suffered from a lack of midwives.
Hobart Private Hospital cited difficulties in maintaining an adequate workforce as the primary reason for the decision to stop delivering babies.
Further, a January review found problems at the Royal Hobart Hospital relating to a shortage of trained midwives.
Transition project lead Saman Borazjani said Calvary had faced the same hiring challenges as hospitals across Australia, but they were being overcome.
Calvary's clinical services director Leah Magliano said the response to the hiring campaign had "surpassed expectations".
"We will absolutely have the required amount of staff that we'll need," she said.
A spokesperson for the Australian Nursing and Midwifery Foundation said it was supporting members through the transition.
In the aftermath of Hobart Private Hospital's maternity closure, the federal government announced it would invest $6 million to help meet an increase in demand for public and private maternity services.
Calvary said it was using its share of the funding for new equipment and capital works, including upgrading one of its five birthing suites.
Mr Borazjani said five new special care nursery bays would be built.
"A lot of these works have been done in conjunction with not losing any capacity with our current occupancy and workflow.
Meanwhile, Hobart Private is deciding how to best use the 28-bed ward that is currently being used for maternity, with the final birth expected in August.
General manager Georgia Banks said the community's needs were being considered in relation to future plans for the ward.
"It's a lot of space and we know how valuable space is in any hospital, so we absolutely have that at the forefront of our mind," Ms Banks said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Victoria to open Australia's second permanent pill testing site
Victoria to open Australia's second permanent pill testing site

SBS Australia

time2 hours ago

  • SBS Australia

Victoria to open Australia's second permanent pill testing site

The service will offer testing for most substances - and act as an early detection point for authorities on the lookout for highly dangerous synthetic opioids such as fentanyl and Nitazenes, which can be mixed with other drugs. The decision puts Victoria in a unique position on drug policy, as Australia's states and territories grapple with how to balance harm minimisation with increasingly tough law and order approaches. Listen to the full story on our podcast. SBS Japanese 18/06/2025 06:48 Listen to SBS Japanese Audio on Tue, Thu and Fri from 1pm on SBS 3. Replays from 10pm on Tue, Thu and Sat on SBS1. Listen to past stories from our podcast. Download the free SBS Audio App and don't forget to visit SBS Japanese Facebook and Instagram page!

Australia's sunscreen showdown — and why SPF might be misunderstood
Australia's sunscreen showdown — and why SPF might be misunderstood

SBS Australia

time2 hours ago

  • SBS Australia

Australia's sunscreen showdown — and why SPF might be misunderstood

Some of Australia's most popular sunscreens are not meeting their own SPF rating claims, according to Choice, which recently tested 20 products. Source: Getty / Amparo Garcia A popular sunscreen brand is at the centre of controversy after a consumer group's study claimed it failed to meet its advertised Sun Protection Factor (SPF) 50+ protection ratings, but an expert says the metric is widely misunderstood. Choice, which tested 20 SPF50 or 50+ sunscreens in an "external laboratory that has specialist expertise and equipment", found that only four met their SPF claims, while 16 failed. The worst performer, according to the results — Ultra Violette's Lean Screen SPF 50+ Mineral Mattifying Zinc Sunscreen, which returned a rating of four — has rejected the findings, questioning the validity of the group's testing methodology. Michelle Wong, a cosmetic chemist and a science communicator at Lab Muffin Beauty Science, said: "I think a lot of people expect that SPF is a very solid number when in reality it's not." "The more you apply, the less the variation in SPF matters. If you're applying, let's say half of an SPF50, you would get SPF25," she told SBS News. Wong said the bigger concern is under-application, as studies show people often tend to underapply their sunscreens. "If you apply enough of the recommended amount [of sunscreen], then anything above SPF30 is going to give a lot of protection," she said. Ultra Violette has strongly refuted Choice's test results and said it is continuing to investigate. A statement on its website said: "Lean Screen contains 22.75 per cent zinc oxide, a level at which, when applied sufficiently, would render a testing result of SPF4 scientifically impossible." The brand's co-founder, Ava Chandler-Matthews, accused Choice of using unreliable testing methods in a social media post. The brand's website states Lean Screen had recorded an SPF of 64.32 in 2021, as per internal testing conducted to support the product's listing in the public database — the Australian Register of Therapeutic Goods. Then, in April 2025, it retested the same batch used by Choice, yielding a result of SPF 61.7, as stated on their website. Ultra Violette has also criticised the advocacy group for testing what it says was a "small" batch of the product. "Two blind tests with a very small sample size are not substantial in comparison to the extensive rounds of testing with supporting documentation Ultra Violette have conducted in accordance with the TGA [Therapeutic Goods Administration] testing guidelines," a statement said. In response, Choice CEO Ashley de Silva doubled down on its methodology and findings, saying: "CHOICE stands by its rigorous, independent sunscreen testing, conducted under the guidance of industry experts in specialised, accredited laboratories." Choice said all products were blind-tested by a 10-person panel. The sunscreens were decanted into amber glass jars (which block UV light and prevent ingredient breakdown), sealed, labelled, and transported by a Sydney-based accredited lab. "After Ultra Violette's product returned an SPF of 4 when tested at the Sydney lab, we sent a different batch to an accredited, specialised laboratory in Germany, the Normec Schrader Institute, for a validation test," de Silva said. The validation test returned an SPF of 5. Cancer Council Australia — whose three products missed the mark according to Choice's test results — said white it is concerned about the findings, separate testing by its product sponsor has shown "compliance with their labelled SPF rating". It also acknowledged SPF testing, conducted on human skin, "can produce variable results between laboratories, even when the same standards are followed". The TGA last week said it was investigating the Choice findings. The medicines watchdog said there could be variability in SPF testing results across laboratories, due to the reliance on human subject testing. It said a number of the Choice-tested products returned results in the range of SPF 30, which provide "high protection" and are effective. "Given Australia's high incidence of skin cancer, the TGA reiterates that using sunscreen is an important measure to prevent harmful effects of ultraviolet radiation, in addition to seeking shade, wearing a wide-brimmed hat, wearing protective clothing and using sunglasses," the TGA said. Makeup-compatible sunscreens are desirable for their non-greasy, non-chalky and zero-white cast finish. While suitable sometimes, including for indoor or shady activity, Wong said "cosmetically elegant sunscreens" are ultimately "less robust". " The protection you get from a sunscreen depends a lot on how intact that sunscreen layer is. To make a sunscreen stay on your skin in an intact layer, a lot of the time you have to sacrifice texture," she said. "If you are getting lots of exposure, generally water resistance is a good thing to look for because that means it's been tested in quite extreme conditions, which means it should last through a lot of activity." She also urged other sun safety practices, including wearing layered clothing. Share this with family and friends

One person has died after an outbreak of legionnaires' disease in Sydney
One person has died after an outbreak of legionnaires' disease in Sydney

News.com.au

time3 hours ago

  • News.com.au

One person has died after an outbreak of legionnaires' disease in Sydney

One person has died following an outbreak of legionnaires' disease in Sydney's CBD prompting authorities to issue a health alert. NSW Health said 12 people who spent time in the city and surrounding suburbs between March and April had contracted the deadly disease. 'Sadly, one of the people who contracted the disease passed away in hospital last week,' a NSW Health spokesman said on Wednesday. Authorities tested more than 165 cooling towers in the city and detected legionella bacteria in one. The cooling tower is being decontaminated and further tests are being conducted to determine if it was the source of the outbreak. Anyone who was in the Sydney CBD and surrounding suburbs between March and April is urged to be aware of symptoms including fever, chills, coughing and shortness of breath. Symptoms can develop up to 10 days after exposure and anyone who experiences symptoms should see their doctor. South Eastern Sydney Local Heath District Public Health Unit Director Vicky Sheppeard said 11 people with the disease had been hospitalised and one person received care out of hospital. 'Legionnaires' disease is caused by infection with legionella bacteria,' Dr Sheppeard said. 'Outbreaks sometimes occur when bacteria from environmental sources such as cooling towers atop large buildings become contaminated. It is not spread from person to person. 'NSW Health continues to work closely with the City of Sydney to identify, inspect and sample any cooling towers in the CBD potentially implicated in the outbreak. 'Most building owners have responded quickly to ensure that their cooling towers are operated and maintained in compliance with the NSW Public Health Regulation 2022.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store